Skip to main content
INVITES BIOCORE CO., LTD logo

INVITES BIOCORE CO., LTD — Investor Relations & Filings

Ticker · 216400 ISIN · KR7216400002 KO Professional, scientific and technical activities
Open in API
Filings indexed 169 across all filing types
Latest filing 2026-04-30 Notice of Dividend Amou…
Country KR South Korea
Listing KO 216400

About INVITES BIOCORE CO., LTD

https://www.bio-core.com/eng/main/main.…

INVITES BIOCORE CO., LTD. is a Contract Research Organization (CRO) that provides comprehensive services to support new drug development. Established in 2001, the company partners with pharmaceutical firms, research institutes, and medical institutions. Its primary services include bioanalytical testing, central lab services, and clinical trial support. The company also specializes in genomic analysis, offering genetic and cell screening, individual genome analysis, and related services to facilitate the advancement of precision medicine and personalized healthcare.

Recent filings

Filing Released Lang Actions
[기재정정]현금ㆍ현물배당결정 (중간배당)
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement regarding the decision and correction of a cash and in-kind dividend payment, specifically an interim dividend (중간배당). It includes information about the dividend amount per share, total dividend amount, dividend record date, payment date changes, and board resolution dates. The document is relatively short (4350 characters) and focuses on dividend details and changes to payment schedules. It does not contain comprehensive financial statements or full financial performance data. This type of document fits the category of a Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder information.
2026-04-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is the official results of the regular shareholders’ meeting (정기주주총회 결과), listing agenda items, vote tallies, approval status, record date and other meeting details. This corresponds to “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-03-30 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted by the company '인바이츠바이오코아'. It provides a summary of the audit opinion (적정/Unqualified), key financial data (assets, liabilities, revenue, profit/loss), and auditor information. While it contains financial data, it is a summary announcement of the audit report filing rather than the full annual report (10-K) or a standalone audit report document. According to the 'Menu vs Meal' rule, this is a notification of the report's submission, which falls under the Report Publication Announcement (RPA) category. FY 2025
2026-03-20 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Invite BioCore' (인바이츠바이오코아) for the fiscal year ending December 31, 2025. It includes the independent auditor's opinion, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a standalone audit report and not a full Annual Report (10-K) or a simple announcement, fitting the definition of an Audit Report (AR). FY 2025
2026-03-20 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Invites BioCore. It outlines the date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and details of the board nominees. This document serves as the official materials sent to shareholders to provide information and request votes for the upcoming meeting, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2026-03-13 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for In2IT BioCore. It contains the meeting agenda, date, location, and detailed management information including business reports, financial statements, and board activities. This document is a formal proxy statement and notice sent to shareholders to inform them of the upcoming AGM and solicit their votes, which fits the definition of a Proxy Solicitation & Information Statement.
2026-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.